Minnesota’s share of a $71 million multistate settlement with biotech drugmaker Amgen tops $1.2 million. The deal to end an investigation into illegal marketing of two drugs made by the company was announced earlier this week. Court papers filed in Minnesota say the state’s portion will go toward individuals who experienced harm, administrative costs and the general treasury if any is left.
Following a hush-hush courtship, top Minnesota lawmakers acknowledged Tuesday that they are compiling a multi-million dollar package of public subsidies and tax breaks to encourage an Illinois-based pharmaceutical firm to add 200 high-paying jobs and undertake a substantial construction project in their state.
American Crystal Sugar’s board of directors has decided to have the cooperative’s farmer members plant biotech sugar beet seed again this year, despite a federal court challenge by opponents of genetically modified beets.
Gov. Mark Dayton and U.S. Sen. Al Franken are praising a biotechnology company that plans to expand in Coon Rapids, Minn., with state and city help.